首页> 外文期刊>Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie >Long term follow-up after a single intravitreal ranibizumab injection for choroidal neovascularisation secondary to optic nerve head drusen in a 5-year-old child
【24h】

Long term follow-up after a single intravitreal ranibizumab injection for choroidal neovascularisation secondary to optic nerve head drusen in a 5-year-old child

机译:玻璃体腔内雷珠单抗单次注射治疗5岁儿童继发于视神经乳头继发脉络膜新生血管后的长期随访

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Dear Editor, A 5-year-old boy presented with a 10-day history of blurred vision in his left eye. Visual acuity (VA) was 20/60. Fundu-scopy, ultrasonography, and Fluorescein/ICG angiographies (Fig. 1) associated with optical coherence tomography (OCT) (Fig. 2a,b) revealed a classic choroidal neovascular (CNV) membrane complicating buried optic nerve head drusen (ONHD). After an informed consent was obtained, the patient underwent an intravitreal ranibizumab injection (0.5 mg) under general anaesthesia. VA improved to 20/30 at month 1, 20/25 at month 2 and remained stable over a 12-month follow-up period. No recurrence of the neovascular activity was observed (Fig. 2c,d).
机译:亲爱的编辑,一个5岁的男孩左眼出现视力模糊10天的病史。视敏度(VA)为20/60。与光学相干断层扫描(OCT)相关的眼底检查,超声检查和荧光素/ ICG血管造影术(图1)(图2a,b)显示了经典的脉络膜新生血管(CNV)膜,使埋入的视神经头玻璃疣(ONHD)复杂化。在获得知情同意后,患者在全身麻醉下接受玻璃体内兰尼单抗注射(0.5 mg)。 VA在第1个月提高到20/30,在第2个月提高到20/25,并在12个月的随访期内保持稳定。没有观察到新血管活性的复发(图2c,d)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号